Radnor, Pennsylvania–(Newsfile Corp. – April 19, 2024) – The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit against Doximity, Inc. (NYSE: DOCS) (“Doximity” or the “Company”) on behalf of investors who purchased or acquired Doximity common stock between February 9,

Each year, Earth Day invites us to consider what we can do as individuals to help solve environmental problems. It offers a backdrop to gauge progress on issues ranging from plastics pollution (the theme of this year’s Earth Day) to biodiversity, land use, a just transition, and climate change. It provides a context to evaluate

US stocks edged lower on Friday as investors assessed Israel’s strike against Iran. The missile strike was limited and is seen as symbolic and could serve as an off-ramp to avoid further conflict. Oil prices spiked more than 3% in wake of the attack, but has since erased all of those gains. Thanks for signing

Key Insights The projected fair value for ClearPoint Neuro is US$4.02 based on 2 Stage Free Cash Flow to Equity Current share price of US$5.39 suggests ClearPoint Neuro is potentially 34% overvalued Analyst price target for CLPT is US$10.00, which is 148% above our fair value estimate In this article we are going to estimate